Latest Advisory

  • FDA Advisory No. 2016-144-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” na gawa ng The ACME Laboratories Ltd. – Dhaka, Bangladesh

    FDA Advisory No. 2016-144-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” na gawa ng The ACME Laboratories Ltd. – Dhaka, Bangladesh

    Read more

  • FDA Advisory No. 2016-144 || Public Health Warning Against the Use of the Unregistered Drug Product “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” manufactured by The ACME Laboratories Ltd. – Dhaka, Bangladesh

    FDA Advisory No. 2016-144 || Public Health Warning Against the Use of the Unregistered Drug Product “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” manufactured by The ACME Laboratories Ltd. – Dhaka, Bangladesh

    Read more

  • FDA Advisory No. 2016-143-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    FDA Advisory No. 2016-143-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    Read more

  • FDA Advisory No. 2016-143 || Public Health Warning Against the Use of the Unregistered Drug Product “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    FDA Advisory No. 2016-143 || Public Health Warning Against the Use of the Unregistered Drug Product “Puritan’s Pride Premium Folic Acid 400 mcg Tablet”

    Read more

  • FDA Advisory No. 2016-142-A || Babala sa Publiko Tungkol sa Paggamit ng mga Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-142-A || Babala sa Publiko Tungkol sa Paggamit ng mga Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-142 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2016-142 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    Read more

  • FDA Advisory No. 2016-141-A || Babala sa Publiko tungkol sa Paggamit ng mga Pekeng Gamot na:

    FDA Advisory No. 2016-141-A || Babala sa Publiko tungkol sa Paggamit ng mga Pekeng Gamot na:

    Read more

  • FDA Advisory No. 2016-141 || Public Health Warning Against the Use of the Following Counterfeit Drug Product:

    FDA Advisory No. 2016-141 || Public Health Warning Against the Use of the Following Counterfeit Drug Product:

    Read more

  • FDA Advisory No. 2016-140-A || Babala sa Publiko Tungkol sa Paggamit ng Pekeng Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    FDA Advisory No. 2016-140-A || Babala sa Publiko Tungkol sa Paggamit ng Pekeng Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    Read more

  • FDA Advisory No. 2016-140 || Public Health Warning Against the Use of the Counterfeit Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    FDA Advisory No. 2016-140 || Public Health Warning Against the Use of the Counterfeit Albumin (Human) U.S.P. Human Albumin Grifols 25% Solution “Manufactured by Instituto Grifols, S.A., Barcelona, Spain”

    Read more

  • FDA Advisory No. 2016-133-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-133-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-133 || Public Health Warning Against the Use of the Following Unregistered Drug Product:

    FDA Advisory No. 2016-133 || Public Health Warning Against the Use of the Following Unregistered Drug Product:

    Read more

  • FDA Advisory No. 2016-139-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Curing Pill”

    FDA Advisory No. 2016-139-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Curing Pill”

    Read more

  • FDA Advisory No. 2016-139 || Public Health Warning Against the Use of the Unregistered Drug Product “Curing Pill”

    FDA Advisory No. 2016-139 || Public Health Warning Against the Use of the Unregistered Drug Product “Curing Pill”

    Read more

  • FDA Advisory No. 2016-138-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    FDA Advisory No. 2016-138-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    Read more

  • FDA Advisory No. 2016-138 || Public Health Warning Against the Use of the Unregistered Drug Product “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    FDA Advisory No. 2016-138 || Public Health Warning Against the Use of the Unregistered Drug Product “Double J Go Shi Ashitaba + Guyabano (Angelica Keskei + Soursop) Liniment”

    Read more

  • FDA Advisory No. 2016-137-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-137-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-137 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2016-137 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    Read more

  • FDA Advisory No. 2016-136-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Jinling Bao Ji Pill”

    FDA Advisory No. 2016-136-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Jinling Bao Ji Pill”

    Read more

  • FDA Advisory No. 2016-136 || Public Health Warning Against the Use of the Unregistered Drug Product “Jinling Bao Ji Pill”

    FDA Advisory No. 2016-136 || Public Health Warning Against the Use of the Unregistered Drug Product “Jinling Bao Ji Pill”

    Read more

FDA Circular No. 2016-018

New FDA Director General

In the interest of continuing public service to the consumers, industries, other government agencies and concerned parties, you are hereby informed that the new Director General of the Food and Drug Administration effective 19 August 2016, is:

NELA CHARADE G. PUNO, RPh
FDA Director General
Department of Health

For your information and guidance

 

Public Consultation on the Draft Implementing Rules and Regulations of Republic Act No. 10918, otherwise known as the Philippine Pharmacy Act

On 21 July 2016, Republic Act (RA)No. 10918, otherwise known as the Philippine Pharmacy Act, was passed with the following objectives:

 

To continue reading download the attachment...

 

 

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter